NCT05622058 2023-02-27A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast CancerAileron Therapeutics, Inc.Phase 1 Terminated6 enrolled
NCT00529282 2012-08-01A Study of Ceftobiprole in Patients With Fever and Neutropenia.Basilea PharmaceuticaPhase 3 Terminated2 enrolled 4 charts